VIBAPAPOGENE AUTOLEUCEL
UNII M6CQK5YE94

Substance Identification & Data

This profile provides standardized clinical and technical data for Vibapapogene Autoleucel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) M6CQK5YE94.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
M6CQK5YE94
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
VIBAPAPOGENE AUTOLEUCEL
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C203050
National Cancer Institute reference terminology for clinical and research data.
INN ID
11403
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
ITIS TSN
180092
Taxonomic Serial Number for species identified in the Integrated Taxonomic Information System.
NCBI Taxonomy
9606
Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vibapapogene Autoleucel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VIBAPAPOGENE AUTOLEUCEL

Common Names & Synonyms

AUTOLOGOUS PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) EXPRESSING HUMAN PAPILLOMAVIRUS TYPES 16 & 18 ANTIGENS
AUTOLOGOUS PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS), SPECIFICALLY B LYMPHOCYTES AND MONOCYTES THAT ARE T-CELL DEPLETED, TRANSFECTED EX VIVO WITH A NON-REPLICATING ADENOVIRAL VECTOR THAT EXPRESSES A CODON-OPTIMISED FUSION OF TUMOUR-ASSOCIATED ANTIGENS (TAAS) E6 AND E7 DERIVED FROM HUMAN PAPILLOMAVIRUS (HPV) TYPES 16 AND 18 (HPV-16/18 E6/E7). THE ANTIGEN CODING REGION IS PRECEDED BY A TPA SIGNAL SEQUENCE AND TRANSCRIPTION IS UNDER THE CONTROL OF THE CYTOMEGALOVIRUS (CMV)-TETRACYCLINE 10 PROMOTER AND THE SV40 POLY(A) TERMINATION SEQUENCE. THE VECTOR GENOME IS FLANKED BY INVERTED TERMINAL REPEATS AND CONTAINS AN ENCAPSIDATION SIGNAL AND A K35 KNOB
VIBAPAPOGENE AUTOLEUCEL [INN]

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus